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the discovery of key molecules dictating immunity and/or 
tolerance, and for understanding the complex interplay that 
takes place between mucosa, airway epithelium and resi-
dent or infiltrating immune cells. This review focuses on cur-
rent knowledge and the advantages and limitations of the 
different cell types and culture methods used in co-culture 
models of the human airways.  © 2016 S. Karger AG, Basel 
 Introduction 
 All cavities and surfaces throughout the body contain 
a layer of epithelial cells and are thus often the first cells 
to interact with external antigens. The skin is the most 
straightforward example but the lumen of the intestines 
and airways also include an epithelial cell layer to protect 
the physiological ‘interior’ against harmful external 
pathogens or noxious substances. Due to its role as an in-
terface, many diseases involve the epithelium in various 
ways, even with pathogens that are not primarily aimed 
at the epithelia. In order for pathogens to gain entry to 
their target organs, they need to pass and interact with the 
epithelium, and this may involve cell damage and necro-
sis. With as much as 15,000 litres of air passing through 
our lungs every day, we are constantly exposed to a mul-
titude of pollutants, environmental allergens and patho-
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 Abstract 
 Epithelial cells line all cavities and surfaces throughout the 
body and play a substantial role in maintaining tissue ho-
meostasis. Asthma and other atopic diseases are increasing 
worldwide and allergic disorders are hypothesized to be a 
consequence of a combination of dysregulation of the epi-
thelial response towards environmental antigens and genet-
ic susceptibility, resulting in inflammation and T cell-derived 
immune responses. In vivo animal models have long been 
used to study immune homeostasis of the airways but are 
limited by species restriction and lack of exposure to a natu-
ral environment of both potential allergens and microflora. 
Limitations of these models prompt a need to develop new 
human cell-based in vitro models. A variety of co-culture sys-
tems for modelling the respiratory epithelium exist and are 
available to the scientific community. The models have be-
come increasingly sophisticated and specific care needs to 
be taken with regard to cell types, culture medium and cul-
ture models, depending on the aim of the study. Although 
great strides have been made, there is still a need for further 
optimization, and optimally also for standardization, in order 
for in vitro co-culture models to become powerful tools in 
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gens of different kinds. Not all of these exposures are po-
tentially harmful. One of the airway epithelium’s main 
functions, besides providing a structural barrier and al-
lowing respiration to proceed, is to help maintain homeo-
stasis by assisting our immune cells to distinguish be-
tween harmful and harmless exposure. When this mech-
anism fails we experience inflammatory reactions against 
antigens that are not inherently dangerous, for example 
environmental allergens, and repeated exposures togeth-
er with the memory of our adaptive immunity lead to del-
eterious reactions that may develop into a chronic state of 
disease.
 Asthma and other atopic diseases are increasing world-
wide. It has been hypothesized that allergic disorders may 
be a consequence of complex interactions between envi-
ronmental allergens and epithelial tissues combined with 
genetic susceptibility resulting in T cell-derived immune 
responses  [1] . Resident and circulating antigen-present-
ing cells, primarily dendritic cells (DCs), continuously 
sample their environment at epithelial surfaces. These 
sentinel cells express a variety of pattern recognition re-
ceptors (PRRs), such as Toll-like receptors (TLRs), recog-
nizing pathogen-associated molecular patterns (PAMPs) 
and danger-associated molecular patterns (DAMPs). 
When exposed to PAMPs or DAMPs, DCs are able to or-
chestrate immune responses by migrating to local drain-
ing lymph nodes and presenting antigens to T cells. 
Through cell-to-cell contact and the production of cyto-
kines and chemokines, DCs play an important part in the 
polarization of T cell responses, and hence for the activa-
tion and recruitment of other inflammatory cells to the 
epithelial tissue  [2] . The maturation and polarization of 
DCs in response to many pathogens have both been well 
studied, but interactions between the epithelium and DCs 
while they sample antigens are likely to also instruct and 
modulate DC responses. Other, more newly identified 
cell types, such as type 2 innate lymphoid cells (ICL2), 
may also play important roles in epithelial type 2 respons-
es. ICL2s produce type 2 cytokines in response to epithe-
lial-derived IL-25 and IL-33, and furthermore appear to 
represent the majority of IL-5- and IL-13-producing lung 
cells in murine asthma models  [3–6] . The epithelial co-
ordination of immune responses has become a field of 
increasing interest with emerging theories viewing aller-
gy and asthma at least partially as a result of epithelial 
disorders. The theory is that persistent type 2 responses 
are a symptom of erroneous-instructed antigen-present-
ing cells combined with a Th2-biased microenvironment 
in both the local environment and the lymphatic tissues 
of the airways. Whether homeostasis in non-allergic in-
dividuals is maintained due to the triggering of mecha-
nisms that are not present in certain individuals geneti-
cally susceptible to allergy, or if allergic individuals have 
an exaggerated response towards antigens, is still debated 
 [7, 8] . There are now emerging data supporting the belief 
that epithelial cell barrier dysfunction leads to an over-
zealous immune activation  [9–13] . 
 In vivo animal models have long been used to study 
homeostasis in the lungs but are often hampered by a lack 
of functional homology between animal and human mol-
ecules, a lack of lengthy exposure to environmental fac-
tors and a lack of unknown predisposing genetic poly-
morphisms. Dissecting how tissue-specific non-immune 
cells and DCs co-operate in co-ordinating tissue homeo-
stasis and inflammation in humans, for example, has 
multiple practical problems and there is a need to develop 
new cell-based in vitro human tissue models to overcome 
many of the limitations with animal models. Many of the 
existing in vitro models were initially used to study mech-
anisms of drug uptake across the epithelium but have be-
come increasingly sophisticated, and can now be used to 
study cell-cell and cell-matrix interactions during ho-
meostasis and inflammation  [14–19] . This review focuses 
on the advantages and limitations of the different cell 
types and culture conditions applied in co-culture models 
of the airways, aiming to study cell-cell interaction be-
tween the airway epithelium and their neighbouring in-
nate immune cells.
 The Airway Epithelium 
 Epithelial Morphology of the Airways and Danger 
Signalling 
 ‘The airways’ is a collective term encompassing all tis-
sues involved in the transportation and exchange of gases. 
It is normally divided into the upper airways, comprising 
the nose, the nasopharynx and the larynx, and the lower 
airways, comprising the trachea, the bronchi, the bron-
chioles and finally the alveoli, where the gas exchange 
takes place ( fig. 1 )  [20] . There are several structural and 
cellular mechanisms within the airways that help to pro-
tect them against harmful material and potential patho-
gens. A surfactant film is present along the lower airways 
 [21, 22] and, together with the mucociliary escalator of 
the upper airways, matter can be transported and re-
moved back up the airways where it can subsequently be 
swallowed into the esophagus  [23] . Innate cell popula-
tions such as macrophages (professional phagocytes) are 
also constantly present in the airways and in the alveoli, 
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and a population of DCs resides inside and underneath 
the airway epithelium  [24, 25] . Lastly, there are specific 
tight junction (TJ) complexes maintaining the structural 
integrity of the epithelial layer between the cells  [26, 27] .
 The upper airway epithelium is lined by predominant-
ly ciliated columnar cells together with goblet cells, 
whereas the epithelium in the lower airways is dominated 
by cuboidal ciliated cells together with Clara cells  [28] . 
Apart from these tissue-specific cells within the epitheli-
um there are also a variety of non-epithelial migratory 
cells, such as lymphocytes, leukocytes and mast cells  [29] . 
Moving further down the respiratory system to the alve-
oli there are two main epithelial cell types. The squamous 
alveolar type I pneumocytes are responsible for the gas 
exchange and cover roughly 96% of the alveolar surface 
area  [30] , whereas the smaller cuboidal alveolar type II 
(ATII) pneumocytes, which cover about 3% of the alveo-
lar surface, are responsible for synthesizing and secreting 
antimicrobial and surface-active components  [31] . Alve-
olar type I pneumocyte cells lack the ability to renew 
themselves but are generated from type II pneumocytes.
 In parallel with DCs, epithelial cells are also equipped 
to recognize PAMPs through specialized PRRs such as 
TLRs  [32] . However, as TLRs and other PRRs in essence 
are unable to discriminate between pathogenic and non-
pathogenic microorganisms, other mechanisms are in-
volved to maintain a correct balance between immune 
homeostasis and activation in a non-sterile environment 
such as the airways. These are likely to involve the recog-
nition of DAMPs, and several concepts of organ-specific 
and graded immune responses have been proposed in the 
last couple of years to answer some of these questions 
 [33] . According to some of these, the different organs 
sense infectious danger in different ways depending on 
their natural morphology and physiology, and act upon 
danger to modulate and instruct local immune responses 
thereafter  [33] . For example, in sterile environments such 
as in the spleen, maximum sensitivity and immune acti-
vation towards any pathogen recognition is expected. In 
the opposite case where there is constant microbial expo-
sure, as in the colon, the natural response is instead toler-
ance where recognition by PAMPs needs to be constantly 
suppressed. As the airways are not sterile but not as heav-
ily exposed to microbes as the colon, a more graded re-
sponse would be necessary to uphold homeostasis  [34] .
 There have been several studies showing that the sen-
sitivity and the activation threshold of TLRs in bronchial 
epithelial cells are indeed regulated  [35] , supporting the 
concept that alveolar epithelial cells (AECs) actively dis-
criminate between potential danger signals. One such 
mechanism is the bronchial epithelium’s hyporespon-
siveness towards Gram-positive bacteria, due to low ex-
pression of TLR2 and a lack of expression of CD36, which 
mediates the phagocytosis of Gram-positive bacteria  [35, 
36] . Others have shown that certain micro-organisms or 
aeroallergens may function as adjuvants for epithelial ac-
tivation in both protease-dependent and independent 
manners  [37, 38] . The airway epithelium also maintains 
a steady-state condition by producing anti-inflammatory 
cytokines, such as TGF-β and indoleamine 2,3-dioxygen-
ase, which suppress T cell-mediated immunity, as well as 
the activation of antigen-presenting cells  [34, 39] .
 In an inflammatory setting, the activation of PRRs on 
epithelial cells leads to the release of cytokines, chemo-
kines and antimicrobial peptides that are both able to at-
tract and activate innate and adaptive immune cells. It is 
plausible that prior exposure to DAMPs and PAMPs al-
ters the activation threshold of epithelial cells, which 
could either increase the expression of PRRs themselves 
or other signalling proteins downstream of PRRs. Epithe-
lial exposure to cigarette smoke and some respiratory vi-
ruses have been found to upregulate the expression of 
TLR4 and promotes its localization to the cell membrane, 
thereby increasing epithelial responsiveness to subse-
quent endotoxin exposure  [40, 41] . Most PRR signalling 
 Fig. 1. Schematic illustration of the human airways. The human 
airways encompass all organs involved in the process of respiration 
from the site of inhalation at the nasal cavity to the lungs and the 
alveoli, where the exchange of oxygen and carbon dioxide takes 
place. Adapted from Castro and Kraft  [204] . 
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pathways activate the transcription factor nuclear factor-
κB (NF-κB), responsible for the expression of multiple 
genes of inflammatory cytokines  [42] . These signalling 
pathways have primarily been studied in mice, taking ad-
vantage of the model allergen ovalbumin, and have re-
vealed that constitutive activation of NF-κB in AECs was 
sufficient to activate DCs and break inhalational toler-
ance towards ovalbumin  [43] . Inhibition of the expres-
sion of NF-κB in AECs reversely decreased recruitment 
of type 2 effecter cells and reduced airway remodelling 
 [44] . Taken together, it is now clear that AECs not only 
play a crucial role in upholding homeostasis, but are also 
important in the recognition and initiation of immune 
responses towards pathogens.
 Barrier Function and Epithelial Polarization 
 In order for the heterogeneous composition of airway 
epithelial cells to act as a barrier between the air we breathe 
and the body, there is a large variety of TJ protein com-
plexes between neighbouring cells, resulting in variable 
tightness of the epithelium  [26, 27, 45] . TJ formation be-
tween epithelial cells happens during a process known as 
polarization  [46] . Polarization includes the sorting and 
distribution of certain membrane proteins and lipids into 
the three surface domains: apical, basal and lateral. Stud-
ies have shown that proteins move more or less freely be-
tween the lateral and basal domains, and the localization 
of proteins hereto is often referred to as being basolateral. 
The apical domain is faced towards the luminal compart-
ment, the physiological exterior, and contains proteins 
that are important, for example, in absorption and for 
PRRs to recognize any inhaled pathogens.
 The lateral domains include proteins involved in cell-
to-cell interaction between neighbouring cells, with pro-
teins responsible for epithelial cell-to-cell contact and 
with TJs located the most apically, representing a bound-
ary between the apical and basolateral domains  [47] . The 
TJs are made up of three distinct types of transmembrane 
proteins comprising: occludin, claudins and junctional 
adhesion molecules (JAM;  fig. 2 )  [48–50] . The TJ proteins 
are the basis for AEC barrier function and enable control 
of paracellular transport and cellular communication  [46, 
51, 52] . Besides the proteins that are part of the TJ com-
plex there are other cell-to-cell associated proteins, such 
as gap junction proteins (connexins) and transmembrane 
proteins (cadherins), which are linked to both the actin 
cytoskeleton and cell adhesion molecules through intra-
cellular proteins such as catenins  [53–55] . The basal do-
main faces the extracellular compartment, the physiolog-
ical interior, allowing contact with the extracellular ma-
trix as well as with resident and migratory immune cells 
responsible for homeostasis or the triggering of the im-
mune system. Although the intricate machinery respon-
sible for the intracellular changes and the trafficking and 
sorting of membrane proteins in the polarization process 
have been fairly well described  [56, 57] , the organization 
of immuno-related receptors on epithelial cells have yet 
to be fully elucidated.
 E-cadherin is a major component of the TJ complex, 
and its involvement has been associated with inhalation-
al tolerance towards allergens  [58] . E-cadherin expres-
sion is reduced in biopsies from asthmatics and inhibi-
tory signals are transmitted to DCs via E-cadherin inter-
actions between DCs and epithelial cells  [59, 60] . Loss of 
E-cadherin expression leads to decreased epithelial polar-
ization and hampers inhibitory signalling, facilitating al-
lergic sensitization by the activation of DCs  [59] . Loss of 
E-cadherin in cultured epithelial cells has also been found 
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 Fig. 2. The TJ complexes between neigh-
bouring epithelial cells may actually be di-
vided into bona fide TJs and adherence 
junctions. The TJ consists of claudins, JAM 
and occludin, on which ZO-1, 2 and 3 mol-
ecules attach and connect the TJ to the ac-
tin cytoskeleton. The adherence junction 
consists of cadherins associated with dif-
ferent catenins that also attach to the actin 
cytoskeleton of the cells. 
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to enhance the production of inflammatory Th2 cyto-
kines such as thymic stromal lymphopoietin (TSLP), and 
could potentially be an important factor in breaching tol-
erance towards inhaled allergens  [61] . Besides the secre-
tion of TSLP, AECs have also been found to recruit im-
mature DCs by producing CCL20 and β-defensins  [56] , 
as well as several pro-inflammatory cytokines responsible 
for the activation effector cells in type 2 responses, such 
as IL-6, IL-33, IL-25 and GM-CSF  [12, 62–67] .
 Little is known about how airway epithelial integrity 
and the degree of polarization in terms of how receptor 
diversity of the epithelial basolateral and apical domains 
influence immune homeostasis and activation. In the di-
gestive system, unstimulated, polarized epithelial cells of 
the gastric and intestinal mucosa modulate the function of 
local DCs, mainly via the release of soluble mediators, re-
sulting in a non-inflammatory phenotype crucial for 
maintaining homeostasis  [68–71] . The conditioning ei-
ther by direct contact or through soluble factors, or both, 
instructing the DCs on how to polarize ensuing T cell re-
sponses, has been referred to as imprinting  [71] . In the 
airways we have recently shown, using a bronchial epithe-
lial cell line, that a polarized, intact epithelial layer damp-
ens immune responses and maintains homeostasis, even 
when exposed to allergens. DCs in direct contact with po-
larized AECs developed a tolerogenic phenotype when ex-
posed to bacterial components, and AEC-imprinted DCs 
derived from allergic individuals had a decreased ability to 
stimulate autologous T cells after allergen exposure  [72] .
 The continuous exposure to both harmful and harm-
less antigens and the vast surface area of the airways 
makes these defence mechanisms and barrier functions 
crucial  [73] . However, despite the protective properties of 
the airways, respiratory diseases are common and in-
creasing  [74] , resulting in more attention being directed 
towards examining how allergens and certain antigens 
manage to overcome the epithelial barrier and how the 
epithelium responds towards the challenge.
 Epithelial Uptake and Antigen Presentation 
 Besides its role as a protective barrier, the polarized 
epithelium most likely also plays an important part in fa-
cilitating the uptake of antigens and allergens. Proteins, 
which are normally unable to penetrate and move through 
the epithelium, are normally deposited on the luminal 
surface to the apical side. DCs residing underneath the 
epithelium capture these antigens and allergen proteins 
without affecting the epithelial integrity  [75] . The exact 
mechanism by which the DC dendrites cross the TJs and 
sample these molecules is still not clear  [76] . In gut mu-
cosa, sub-epithelial DCs capture antigens across the epi-
thelial barrier by extending fine cytoplasmic dendrites be-
tween the epithelial cells and through their TJs  [77, 78] . 
The DCs express certain TJ proteins that fuse with the 
epithelial TJs to reach across the epithelial cells, without 
disturbing the structural integrity. This mechanism has 
also been reported in situ for the human nasal mucosa, 
where dendrite extension was shown to penetrate beyond 
well-developed epithelial TJs  [73, 79] . However, the epi-
thelium itself may also be involved in the transport and 
uptake of allergens. Recent observations indicated that 
the timothy grass allergen Phl p 1 is rapidly transported 
through the epithelium by an active process, but this was 
only observed through the epithelium in allergic patients, 
and not in healthy subjects  [80] . Studies done with the 
birch allergen Bet v 1 on nasal epithelium showed similar 
results, with the allergen only taken up in patients allergic 
to birch and not in healthy controls  [81, 82] . These find-
ings support new emerging theories that allergy and asth-
ma may be driven by epithelial dysfunction. This empha-
sizes further the need to establish robust AEC models to 
better elucidate the mechanisms behind the antigen sam-
pling across the epithelium. Lastly, AECs, and specifical-
ly ATII pneumocytes, express MHC class II molecules 
and can act as antigen-presenting cells upon microbial 
activation  [83] . The type II cells have subsequently been 
shown to directly present antigens to T cells and may play 
a role in both the priming and re-stimulation of adaptive 
T cell responses  [84] . Although the type II pneumocytes 
express MHC class II molecules, they lack expression of 
co-stimulatory molecules, e.g. CD80 and CD86  [85] . 
Studies have shown that epithelial antigen presentation 
to T cells in the absence of co-stimulatory molecules in 
combination with the secretion of non-inflammatory 
 cytokines, such as TGF-β, leads to the induction of T cell 
anergy and/or regulatory T cell responses  [84, 86] . T cell 
activation and commitment is normally initiated in the 
primary draining lymph node but during inflammation 
bronchoalveolar lymphatic tissue may develop. Under 
such circumstances the direct interaction between epithe-
lial cells and T cells may be of upmost importance for 
regulating the activation of both effector and naïve T cells. 
One would assume that for AECs to be able to present 
antigens and to induce regulatory T cell responses in 
these settings, it is crucial that the epithelium maintains 
its barrier properties and polarization, expressing PRRs 
at the apical domain, while the MHC molecules are ex-
pressed at the basolateral domain. It is therefore impor-
tant for co-culture models investigating AEC interactions 
with other cell types to ensure AEC polarization.
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 Analysis of Epithelial Cell Polarization 
 As discussed, polarization is a key process for estab-
lishing a proper barrier function, and the degree of polar-
ization can be analyzed by measuring different aspects of 
the polarization mechanism. Essentiality, there are three 
strategies to ascertain polarization: (a) expression and lo-
calization of TJ proteins by fluorescence or confocal mi-
croscopy, (b) assessment of barrier function by means of 
diffusion of small tracer molecules or (c) by measurement 
of transepithelial electrical resistance (TEER) across the 
epithelial layer. Several studies have compared these 
strategies and found that they correspond well with each 
other  [87–94] . For practical reasons the measurement of 
TEER appears to be the easiest accessible of the three 
methods, and TEER measurement can be applied rou-
tinely without disturbing the integrity of the AECs and 
thus allowing the same cells to be examined in various 
setups. 
 Fluorescence and Confocal Microscopy-Assisted 
Localization of TJ Proteins 
 Fluorescence and confocal microscopy is another 
widely used method to detect cytoplasmic and membrane 
proteins of the TJs. Illumination in a confocal microscope 
is achieved by scanning one or more focused beams of 
light, usually from a laser, across the specimen. The light 
excites fluorophores conjugated to antibodies, and the 
emitted light is subsequently captured by a confocal mi-
croscope.
 Immunofluorescent staining and fluorescence micros-
copy was traditionally limited in its sensitivity, but with 
improvements in fluorescent conjugates as well as better 
microscopes has made this less of an issue today. To ver-
ify TJ formation in AECs, the most commonly analyzed 
proteins are occludin, E-cadherin or zonula occludens 
(ZO)-1, 2 or 3. In fully differentiated and polarized epi-
thelial cells immunofluorescent staining of TJs produces 
an image with a honeycomb-like pattern when viewed in 
the x-y plane, vertical to the plane of the monolayers 
( fig. 3 ). Some adherence proteins, such as E-cadherin, are 
not located at the upmost apical portion of the mem-
brane, and confocal microscopy also allows for staining 
to be viewed in the x-z plane when visualizing 3D struc-
tures.
 Protocols for preparing samples differ in some details 
between different laboratories but the steps are generally 
similar. Samples need to be washed, fixated and permea-
bilized, and subsequently blocked to minimize back-
ground fluorescence, after which specific antibodies spe-
cific to the desired protein to stain are added. There are a 
multitude of commercially available fluorescently labeled 
secondary antibodies that emit light in different spec-
trums, facilitating the use of several colors simultaneous-
ly. In order to clarify cell placement, the cell nuclei are 
traditionally also stained, most commonly with DAPI 
(4′,6-diamidino-2-phenylindole) that stains the nucleus 
red.
 During preparation, epithelial cell samples are most 
likely cultured on cell culture inserts. In order to avoid 
disruption of the cells prior to confocal analysis the AECs 
can be stained directly on culture inserts. Inserts with the 
AECs can be cut out of their plastic frame and mounted 
on object glass prior to the staining protocol. As with any 
protocol utilizing fluorescent labelling, many of these 
steps need to be done in dim light with the inclusion of an 
anti-fading reagent in the mounting media to prevent the 
loss of fluorescence. 
 Diffusion Studies to Assess Barrier Function 
 One of the main functions of the AECs is to prevent 
the free diffusion of particles across the epithelial barrier. 
This can also be utilized to assess epithelial polarization 
and the establishment of TJs. In vitro models with im-
a
b
c
 Fig. 3. 2D and 3D confocal microscopy images of the airway epi-
thelial cell lines Calu-3 ( a ), 16HBE14o– ( b ) and A549 ( c ), visual-
izing the expression and localization of the TJ protein occludin. 
Cell nuclei were visualized by DAPI (red) and occludin was visual-
ized by Alexa 488-conjugated anti-occludin antibody (green; col-
ors refer to the online version only)  [72] . 
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mortalized epithelial cells have been used for absorption 
and diffusion studies since the late 1980s, initially with 
intestinal epithelial cells, and later with airway epithelium 
 [19, 95] .
 Different compounds cross the epithelial barrier by 
different mechanisms. Most exogenous macromolecules 
with lower molecular weights are most likely absorbed by 
passive diffusion across the airway epithelium via the TJ 
pathways  [96] . Large hydrophilic compounds, such as 
mannitol and dextran, are absorbed through similar 
mechanisms across the epithelium and are therefore of-
ten used as model compounds to analyze the diffusion 
properties of polarized AECs  in vitro. Comparative stud-
ies of solute permeability between in vivo  and in vitro 
 epithelium are limited, but available data for the two most 
commonly used bronchial epithelial cell lines, Calu-3 and 
16HBE14o–, correlate well with primary epithelial cell 
cultures  [97] . Permeability studies with in vitro  epithelial 
cultures are more common and several studies have 
shown a very clear correlation between TEER values and 
diffusion rates of mannitol  [91, 98–101] as well as dextran 
 [92, 102–104] . Further studies by Man et al.  [91] illus-
trated this relationship by the disruption of E-cadherin 
function, resulting in the loss of TEER and increased per-
meability to mannitol and dextran paracellular flux. AEC 
permeability is often presented by calculating a permea-
bility co-efficient (P app ) for a specific compound. This is 
done by the following equation:
 P app = (dc/dt)/(A × C0), (1)
 where dc/dt is the transport rate in mol/s, A is the surface 
area of the membrane in cm 2 and C0 is the initial concen-
tration of the compound added to the apical chamber of 
the AECs in mol/cm 3 . The compound of interest can be 
either radiolabelled or fluorescently labelled. In order to 
calculate the transport rate (mol/s), samples are consecu-
tively obtained from the basolateral medium and the 
measurement of fluorescence or radioactivity allows for 
an estimation of the concentration, and hence of the dif-
fusion across the epithelial barrier.  
 Measurement of TEER 
 When establishing in vitro  models for co-culture stud-
ies, two chamber models are commonly used. This is 
done with cell culture inserts composed of a porous mem-
brane upon which the AECs are cultured. After the AECs 
polarize, the basal and apical surfaces are easily accessed 
on either side of the cell inserts. TEER can then be as-
sessed by measuring the difference in electric potential – 
movements of ions – across the epithelium, which is a 
measure of the tightness of the cell-cell contacts within 
the epithelium. Specialized epithelial volt-ohmmeters are 
commercially available (catalogue No. MERS00002, Mil-
lipore, Billerica, Mass., USA, and catalogue No. EVOM2, 
World Precision Instruments, Sarasota, Fla., USA) and 
used to measure TEER across cell inserts using ‘chopstick’ 
electrodes (catalogue No. MERSSTX03, Millipore, or cat-
alogue No. STX3, World Precision Instruments) that are 
adjustable to enable placement of the electrodes into ei-
ther side of filter inserts in cell culture wells ( fig. 4 )  [105] . 
By inducing an alternating current, the specialized epi-
thelial volt-ohmmeter produces a zero net charge, there-
by eliminating any adverse effects on the AEC layer that 
a static direct current would create. A more detailed sche-
matic of the current and blueprint of a homemade epi-
thelial volt-ohmmeter is provided in online supplemen-
tary figure 1 (see www.karger.com/doi/10.1159/000445833 
for all online suppl. material). The volt-ohmmeter is also 
unaffected by any inherent membrane capacitance and 
membrane voltage when measuring TEER across the cul-
tured AECs.
 The TEER value is calculated by subtracting the elec-
trical resistance of the filter insert in the absence of epi-
thelial cells from the value measured with cells, and then 
by multiplying the result with the surface area of the in-
sert. As a measure of TEER, the resulting unit is given in 
Ω    ·    cm 2 : 
 (2)	 
.TEER Insert Cell insert InsertR A R R%  q 
 where  TEER ( R TEER ) is obtained by measuring the differ-
ence in resistance across culture inserts with AEC cul-
tures  
	 
Cell insertR   
and culture insert without cells 
	 
,InsertR  
and then multiplied with the insert surface area  A Insert (in 
cm 2 ).
 This process requires that the epithelial cell layer is in 
contact with culture medium on both sides, meaning that 
culture models designed to have the epithelial cells at an 
air-liquid interface (ALI), which is discussed later, would 
require the addition of culture medium to the apical side 
for the duration of the measurement.
 The precise definition of what is a relevant degree of 
polarization and what are adequate TEER values differs 
quite a lot among different groups. TEER values are re-
ported within a variable span, even when using the same 
cell lines. These variations are most likely due to differ-
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ences in culture conditions, such as seeding number, use 
of matrix proteins or culture medium, but differences in 
the handling technique and protocol for measurement 
could also play an important role. Working with the 
bronchial cell line 16HBE14o–, our group noticed that 
TEER values could differ by up to 5% depending on how 
long after the addition of culture medium measurements 
were made [unpubl. data]. For primary alveolar epithe-
lial cultures, TEER values of >1,000 Ω     ·     cm 2 have gener-
ally been obtained  [102] , whereas bronchial primary cells 
generally lead to TEER values of 400–4,000 Ω    ·    cm 2  [106] . 
Although, some groups report ‘polarized’ epithelium 
with TEER values as low as 150 Ω    ·    cm 2  [107] , we propose 
that it is rational to set the bar at the lowest TEER ob-
served in cultures with primary airway epithelial cells, at 
approximately 400 Ω    ·    cm 2 . Due to its easiness, the mea-
surement of TEER is the most common way to ascertain 
polarization, but it is highly recommended that it be sup-
plemented by other techniques when characterizing new 
model systems.
 Epithelial Cell Types in Airway Co-Culture Models 
 In short, there are three main approaches to the study 
of cell-cell interactions: in vivo animal experiments, ex 
vivo studies of cells from isolated lung tissue or biopsies 
and, lastly, in vitro cell culture systems using cell lines or 
primary cells in combination with accompanying cells, 
such as DCs. Such in vitro cell culture systems create sim-
plified biological systems in basic science that offer more 
controllable, versatile and reproducible setups compared 
with in vivo and ex vivo systems.
 The characterization and use of epithelial barriers in 
vitro started in the 1980s with the aim of finding an ideal 
cell culture model to study the transcellular transport of 
drugs which would also be robust and reproducible to 
simplify large-scale studies and minimize animal testing 
 [108] . The co-culture models in use today are all based on 
the pioneer work done by Hidalgo et al.  [95] on the intes-
tinal cell line Caco-2, which have been adapted to co-cul-
ture models of the airway epithelium and comprise a large 
span of different setups. In the more basic models, other 
cell types are only exposed to AEC supernatants either by 
the transfer of supernatants from cultured AECs or by 
separating the cell cultures with culture inserts in tran-
swells. This has been done, for example, by Bleck et al. 
 [109, 110] to investigate the impact of diesel exhaust par-
ticles on AEC cytokine production and, with no direct 
contact between the cell types investigated or uptake 
across the epithelium, these models do not necessarily 
utilize polarized epithelium. As airway co-culture models 
become more sophisticated they often include polarizing 
epithelial cells with or without cell culture inserts  [72, 87, 
111–113] . These models can be further utilized to inves-
tigate the additional influence of direct epithelial contact 
on neighbouring cells as well as the effect on uptake across 
the epithelium by innate cells such as macrophages and 
DCs.
 The source of the AECs in co-culture models is also of 
importance and epithelial cells from freshly isolated tis-
sue (primary cultures) or from a continuous cell line can 
be used. Depending on the aim of the co-culture study, 
different epithelial cells can be utilized for optimal results. 
Here we will provide an overview of the most commonly 
used cell types in human airway co-culture studies. Dif-
ferent cell types and characteristics are also summarized 
in  table 1 .
 Primary Cells 
 Primary cultures isolated from tissue will most often 
represent a heterogeneous population of several different 
(epithelial) cell types and each isolate will be unique and 
impossible to fully reproduce. The number of cells will 
also often be a limiting factor when isolating from nor-
mal human airway tissue  [114, 115] , making it difficult 
to co-ordinate large and/or repetitive studies using pri-
mary cells. However, it is also important to emphasize 
that primary epithelial cells represent the native and 
original cells of the microenvironment, which is intend-
 Fig. 4. Measuring TEER across a polarized epithelial cell layer is 
performed in a two-chamber system using a specialized ohm-me-
ter and two chopstick electrodes. 
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ed for study, and in theory the optimal candidate for es-
tablishing epithelial co-culture models. Similarly, pri-
mary bronchial epithelial cells from laboratory animals 
have been in use over the last 30 years  [116–121] . Human 
primary AECs can be obtained in several different ways: 
(a) autopsy of non-cancerous individuals, (b) atraumat -
ic methods or (c) traumatic methods  [121] . Traumatic 
methods also include the surgical removal of nasal polyps 
or biopsies and, together with post-mortem autopsy 
methods, their main advantage is ample cells or tissue 
that can be harvested and used for culture. One disad-
vantage of obtaining cells from surgical procedures is 
that they can rarely be repeated and post-mortem sam-
ples are obviously unique. Epithelial cells obtained from 
polyp surgery are the most frequently reported source of 
excised human nasal tissue and are widely used for pri-
mary cell cultures  [122, 123] . However, polyp epithelium 
has been found to exhibit higher levels of Na + absorption, 
increased Cl – permeability and increased numbers of 
ILC2s in patients with chronic rhinosinusitis compared 
to healthy epithelium  [124] , indicating that AECs from 
nasal polyps may be functionally different than primary 
cells from other parts of the nasal mucosa  [125] . Other 
techniques to obtain primary cells are through atraumat-
ic techniques such as cellular scrapings or brushings. 
These samples can be easier to obtain from the nasal mu-
cosa in comparison with samples from the lower airways. 
In contrast to the more traumatic methods, these tech-
niques can often be done more than once from the same 
donor, albeit cell counts are often lower in comparison 
with traumatic techniques.
 Model systems using primary tracheobronchial epi-
thelial cells from humans were first published over 20 
years ago  [126] . Most of the protocols have been used for 
drug absorption studies, and primary AECs function well 
for a few generations but lose their ability to form TJs af-
ter a couple of generations, and TEER measurements in-
dicate that polarization is lost  [127] . AECs isolated from 
bronchoscopies are terminally differentiated and short-
lived cells that have been shown to have lower metabolic 
capacities than actively growing cells in vivo or in vitro 
 [128] . One study showed that the primary cells failed to 
generate any active ion transport, in addition to losing 
their ability to polarize, after only 4 generations  [127] . 
Although primary bronchial epithelial cells mimic a func-
tional mucosal barrier by depositing extracellular matrix 
proteins and developing TJs and adherence proteins, 
such as MUC5AC, β-tubulin IV, ZO-1 and E-cadherin, 
studies have shown that these abilities may heavily de-
pend on the individual donor  [107, 129] .
 Human alveolar epithelial type II pneumocytes that 
are isolated from normal human lung tissue undergo 
 Table 1.  Physiological features and culture conditions for commonly used airway epithelial cells
Cell type/
name
Origin Phenotype ALI 
culture
TEER, 
Ω∙cm2
TEER ALI, 
Ω∙cm2
TJ-protein 
expression
Reference No.
RPMI 2650 Nasal squamous cell 
carcinoma
Small monolayers Yes 100 200 Yes (at ALI) 109, 113, 114, 
117, 119
Primary 
bronchial ECs
Healthy tissue Mixed, ciliated cells, goblet cells, 
serous cells, basal cells
Yes 400 – 4,000 ∼750 High (localized) 101, 104, 113
16HBE14o– Healthy tissue, 
immortalized
Rounded, cuboidal, non-ciliated No 700 – 2,500 n.a. High (localized) 66, 82, 84, 104, 
118
Calu-3 Adenocarcinoma Non-ciliated (some report ciliated), 
columnar
Yes ∼1,200 ∼600 High (localized) 66, 83, 101, 106, 
107, 111, 118
BEAS-2B Healthy bronchial tissue, 
immortalized
Squamous No 0 – 150 n.a. Low/medium 
(part-localized)
101, 118
Primary 
AECs
Healthy tissue Mixed alveolar type I and II, 
lamellar bodies, squamous cells
Yes >1,000 >1,000 High (localized) 84, 96, 116, 118
A549 Alveolar adenocarcinoma Membrane-bound inclusions, 
alveolar type II-like
No 0 – 150 n.a. Low 
(non-localized)
66, 84, 105, 112, 
115, 120
NH441 Alveolar adenocarcinoma Mixed alveolar type II cells and 
Clara cells
No 300 n.a. n.a. 108, 110, 115
 The ranking of cell types are given according to their location in the airways. ECs = Epithelial cells; n.a. = not applied.
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morphological and histochemical changes, causing them 
to change from type II to type I-like cells  [115] . Several 
studies have also shown that cultured type II pneumo-
cytes differentiate into heterocellular compositions of 
type I and type II pneumocytes. These heterocultures 
form monolayers with well-established TJs and TEER 
above 1,000 Ω     ·     cm 2  [115, 130] . Although this method 
makes it possible to obtain polarized alveolar epithelium 
with a desirable phenotype and intact TJs, it still has some 
limitations. Primary cells from other tissues can often be 
used for at least a couple of generations, but primary 
AECs generally exhibit very limited proliferation in cul-
ture  [106] .
 Even though biopsy samples can lead to higher cell 
numbers than brushings, for example, it is difficult to 
obtain cell yields adequate for large scale studies. This 
makes primary cells an inconvenient alternative for 
large-scale experiments such as drug screening, and pri-
mary cells have thus not been widely utilized for biophar-
maceutical purposes  [131] . Other factors to consider are 
the complicated maintenance and high degree of vari-
ability between donors, which decreases the reproduc-
ibility between experiments, particularly with respect to 
the development of TEER, as the primary cells also have 
a finite lifespan and may be difficult to manipulate. In a 
publication by Lehmann et al.  [90] it is concluded that 
working with primary AECs is much more time consum-
ing than the culturing of epithelial cell lines and, as cul-
tivation time can vary for primary cells, for co-culture 
studies it can be challenging to work with other cells in 
parallel. It should also be mentioned that a ready-to-use 
culture system based on primary human tracheobron-
chial cells has been made commercially available by the 
Mattek Corporation (Epiairway TM , Mattek Corp., Ash-
land, Mass., USA)  [132] . Epiairway TM has been marketed 
for use in drug delivery studies, but has recently been 
used in co-culture studies  [133] . Additionally, Lonza 
(Basel, Switzerland) has recently made a panel of human 
primary bronchial epithelial cells commercially avail-
able, offering the choice of healthy primary cells with 
guaranteed cilia formation, mucin production and high 
TEER levels, or primary cells from a variety of donors 
diagnosed with asthma, COPD or cystic fibrosis. Such 
standardized cultured primary epithelial cells could po-
tentially prove to be great tools in future co-culture stud-
ies. Despite the obstacles mentioned above, and de-
pending on the situation and due to the current lack of 
strongly polarizing alveolar-derived cell lines (TEER 
>4,000 Ω     ·     cm 2 ), primary AECs may be the best choice 
for studies of airway epithelium.
 Primary Cells in ex vivo Models 
 Conducting experiments under ex vivo conditions al-
lows for more controlled conditions than is possible in in 
vivo experiments, but also suffers from similar disadvan-
tages, such as donor and specimen variability and low-
ered reproducibility. As with culture models using pri-
mary cells, one of the main advantages of using ex vivo 
tissues is the ability to perform tests or measurements that 
would otherwise not be possible or ethically acceptable in 
living subjects and still maintain a mixed phenotype. Ex 
vivo models of the airway epithelium have mainly been 
used to study characteristics of the epithelium in patients 
with asthma or allergy, and not to study cellular interac-
tions between immune cells and epithelial cells. One such 
study, published by Allam et al.  [134] ,  investigated epi-
thelial immune responses in tissues from the oral mucosa 
from allergic donors. Excised tissue samples were placed 
in Petri dishes and exposed to FITC-conjugated allergen 
after which migrating tissue antigen-presenting cells, de-
fined as oral Langerhans cells, could be collected and their 
uptake, phenotype, cytokine production and ability to 
prime T cells analyzed  [134] . This is an elegant and simple 
model that to a large extent manages to retain the com-
plex interplay between different cell types within a tissue 
whilst retaining many of the practical issues stated earlier 
with regard to donor-specific variability and availability.
 Primary Cells from Asthmatic Donors 
 The comparison of primary bronchial epithelial cells 
from asthma and non-asthma subjects has been made in 
a number of studies to investigate intrinsic differences in 
the asthmatic epithelium. The AECs from asthmatic pa-
tients exhibit an increased proliferation and secretion of 
inflammatory cytokines in comparison with AECs from 
non-atopics  [135] , and also possess a reduced ability to 
repair mechanical wounds  [136, 137] . Several groups 
have cultured asthmatic epithelial cells, showing that they 
obtain a less differentiated phenotype with increased 
numbers of basal cells and decreased TJ formation  [138, 
139] , and it has even been reported that primary epithe-
lial cells from asthmatics are not able to polarize at all in 
vitro  [51] . 
 Epithelial Cell Lines 
 Epithelial cell lines are more homogenous with little 
phenotypic differentiation compared to primary cells. 
This makes them more stable during culturing and rel-
atively easy to work with. However, due to the transfor-
mation process and clonality, they are at risk of lacking 
important molecules that are otherwise present in vivo. 
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Using cell lines instead of primary cells are also often 
 associated with significantly low costs and reduce the 
variability between different experiments. Several de-
tailed protocols for how to culture and maintain different 
airway epithelial cell lines have been published during the 
last decade, spanning from the nasal epithelium down to 
the alveolar epithelium  [131, 140] .
 RPMI 2650 
 There is presently only one nasal epithelial cell line in 
use for in vitro  studies. The human nasal cell line RPMI 
2650 (ATCC CCL 30) originates from an anaplastic squa-
mous cell carcinoma of the human nasal septum  [141] . The 
karyotype and cytokeratin polypeptide pattern of RPMI 
2650 has been found to closely resemble that of normal hu-
man nasal epithelium  [142, 143] . During culturing, RPMI 
2650 cells grow in sheets of non-ciliated cells instead of 
polarized monolayers and only obtain TEER values of 
around 100 Ω     ·     cm 2  [121] . Compared with TEER values 
obtained using primary cells from the lower airways ( ta-
ble 1 ), the TEER values of RPMI 2650 cells are very low and 
would normally not be considered polarized. However, 
primary nasal epithelial cells from excised human nasal ep-
ithelium also obtain very low TEER values when cultured 
in vitro with groups reporting TEER values below 100 
Ω    ·    cm 2 and other groups reporting values between 360 and 
640 Ω    ·    cm 2 , indicating that in vitro  culture of nasal epithe-
lial cells have yet to be fully optimized  [144, 145] . The ex-
pression of TJ proteins was initially reported to be absent, 
but recent studies with RPMI 2650 cells at an ALI revealed 
the expression of several TJ proteins as well as a doubling 
of TEER  [98, 145, 146] . This suggests that improving cul-
ture conditions could possibly make this cell line more vi-
able for use in future in vitro co-culture models.
 Calu-3 
 One of the most widely used bronchial cell lines is the 
Calu-3 cell line (ATCC HTB-55) derived from a bron-
chial epithelial adenocarcinoma of a 25-year-old Cauca-
sian male  [147] . The cell line shows excellent polarization 
with high levels of the TJ proteins occludin and E-cad-
herin localized at the junctions  [72, 89] ( fig.  3 a). The 
Calu-3 cell line often reaches full polarization after 8–10 
days in culture and obtains TEER values often exceeding 
1,000 Ω    ·    cm 2 , depending on the culture conditions  [106, 
107] . Interestingly, a study comparing Calu-3 cells and 
primary human bronchial epithelial cells found that 
TEER was higher and more robust in the Calu-3 cell line 
than in the primary bronchial epithelial cells. However, 
the expression of ZO-1 was higher in human bronchial 
epithelial cells than in the Calu-3 cells at both the mRNA 
and protein levels, indicating that other TJ proteins play 
a more important role in maintaining a functionally po-
larized barrier  [107] .
 The Calu-3 cell line exhibits serous cell properties and 
forms confluent monolayers of mixed cell phenotypes of 
ciliated and secretory properties and mucus production. 
The ability of the Calu-3 cell line to express cilia appears 
to be highly inconsistent and has only been reported by 
some investigators  [148, 149] , and not by others  [92, 150–
152] . As some groups have reported that the expression 
of cilia seems to disappear with an increasing passage 
number, the discrepancy could be related to the number 
of cell passages  [89, 152] . Calu-3 cells have also been 
found to differentiate and polarize under both liquid-
covered conditions as well as under ALI conditions, as 
discussed below.
 16HBE14o– 
 Another widely used bronchial epithelial cell line, 
16HBE14o–, was developed by the transformation and 
immortalization of normal bronchial epithelial cells ob-
tained from a 1-year-old male heart and lung transplant 
patient. The cells express high levels of the TJ proteins 
occludin and E-cadherin and form TJs ( fig. 3 b)  [19, 72, 
153] . 16HBE14o– cells are smaller and generally rounder 
or more cuboidal in shape compared to the Calu-3 cells, 
which appear to possess a columnar phenotype. The 
16HBE14o– cells retain an epithelial phenotype, as dem-
onstrated for the Calu-3 cells, with TJs and a proper 
 transepithelial resistance  [88, 154, 155] . In parallel with 
Calu-3 cells, there are conflicting reports of whether 
16HBE14o– cells are ciliated or not, but they have been 
shown to express several transport proteins  [88, 155] .
 When cultured under ALI conditions, 16HBE14o– 
cells fail to polarize and do not develop normal epithelial 
phenotypical and morphological traits, unlike the Calu-3 
cell line  [88] . In general, bronchial cell lines are expected 
to function and polarize when cultured at the ALI in vitro 
because epithelial cells are normally located at an air in-
terface in vivo. The inability of the 16HBE14o– cell line 
to polarize under ALI conditions is an exception for 
which the exact reason or mechanism is currently un-
known. Future optimization of culture conditions, such 
as changes in culture medium, and the inclusion of matrix 
proteins for the coating or implementation of other cul-
ture techniques, such as the use of rotating wall vessels 
(RWV, discussed below), could possibly enable the 
16HBE14o– cell line to polarize when cultured at ALI, as 
described for the nasal RPMI 2650 cell line.
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 BEAS-2B 
 The BEAS-2B cell line (ATCC CRL-9609) is available 
from the American Type Culture Collection and derives 
from normal human epithelial cells immortalized using 
the adenovirus 12-simian virus 40 hybrid virus  [156] . The 
cell line has been used to study bronchial epithelial struc-
ture and the expression and activity of drug-metabolizing 
enzymes  [157, 158] . The BEAS-2B cell line does not ap-
pear to polarize and form TJs and only obtains TEER val-
ues below 100 Ω    ·    cm 2 in vitro  [107] . Even though the cell 
line fails to polarize, it has still been used in some co-cul-
ture studies to evaluate the epithelial influence on differ-
ent accompanying immune cells after challenges with to-
bacco smoke, diesel particles or endotoxin  [110, 159, 
160] . These studies have used models where accompany-
ing cells were either mixed together or separated by filter 
inserts, with the accompanying cells being exposed to 
only soluble factors secreted by the BEAS-2B cells  [110, 
159, 160] .
 A549 
 The most frequently used alveolar epithelial cell line 
is the A549 cell line (ATCC CL-185), which is derived 
from a human pulmonary adenocarcinoma  [161] . The 
A549 cells contain multilamellar cytoplasmic inclusion 
bodies, which are typically seen on human lung ATII 
cells, although the inclusion bodies disappear with in-
creasing culture time  [162] . A549 cells are functionally 
deficient in TJs, and most research groups have conclud-
ed that the A549 cell line is unable to polarize and inca-
pable of forming functional TJs  [72, 102, 131, 163–165] . 
However, A549 cells do express certain TJ and adherence 
proteins, such as desmosomes and zonulae adherents, to 
an even greater extent than the 16HBE14o– cells that 
otherwise obtain high TEER values  [165] . The inability 
of A549 cells to polarize also affects protein and dextran 
permeability, which has been reported to be over 2 orders 
of magnitude higher in A549 cells compared with other 
cell lines  [131] . One group has reported TEER of around 
600 Ω     ·     cm 2 with the A549 cell line, although they also 
showed that large hydrophilic molecules translocated 
across the A549 cell layer at rates very close to free diffu-
sion limits  [103] . As this is the only report suggesting that 
the A549 cell line can polarize, the reported TEER mea-
surements may be misleading. We and other groups have 
shown that both occludin and E-cadherin are expressed 
by A549 cells  [72, 166] . However, this expression was rel-
atively low and not localized to the same extent as seen 
for the Calu-3 and 16HBE14o– cell lines ( fig. 3 c). Despite 
its limitations, the A549 cell line is still used in co-culture 
studies, often with the addition of other epithelial cell 
types in order to facilitate a polarized cell layer  [87, 90, 
167] . 
 NCI-H441 
 Besides A549, another human alveolar cell line called 
NCI-H441 (ATCC HTB-174) has been used in some pub-
lished studies. The NCI-H441 cell line originates from a 
human lung adenocarcinoma and has been described to 
have characteristics of both ATII  [168, 169] and bron-
chiolar Clara cells  [170, 171] . Ion transport characteris-
tics of the H441 cells suggest that it forms polarized 
monolayers, although the polarization appears to be 
highly variable with the majority of cultures only reach-
ing TEER values of around 300 Ω     ·     cm 2  [172, 173] . The 
NCI-H441 cell line has been used in co-culture models 
together with endothelial cells in studies aiming to char-
acterize the air-blood barrier, but remains to be tested in 
co-cultures with immune cells  [174, 175] . 
 The Accompanying Co-Cultured Cells 
 The two main applications of airway co-culture mod-
els have been either to investigate the effects on AECs and 
neighbouring cell types in response to antigens, or to de-
velop competent uptake models for drug delivery. One of 
the main reasons for the increased interest in co-culture 
models with airway epithelium together with antigen-
presenting cells is the finding that AECs secrete a variety 
of pro-inflammatory cytokines, especially TSLP, but also 
IL-25, IL-33 and IL-1b, that all seem to play important 
roles in the cross-talk between antigen-presenting cells 
and the epithelium in type 2-mediated immune respons-
es  [64] . Co-culture models provide a powerful tool to un-
derstand the crosstalk between the epithelium and its 
neighbouring cells. However, it is important to carefully 
characterize the phenotype of the accompanying cell type 
with the purpose of ensuring that it has not been activat-
ed due to handling.
 From the onset of developing in vitro models of the 
epithelial surface there has been constant progress in op-
timizing culture conditions for the functional use of 
AECs. This work is still ongoing for many of the epithe-
lial cell lines in use today. In contrast, many of the accom-
panying cell types used in these co-culture models, e.g. 
DCs, have established protocols detailing refined and 
specific culture conditions, but in co-culture setups the 
inclusion of additional cell types in the form of AECs is 
not always trivial in order to preserve the integrity of both 
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cell types. Antigen-presenting cells, such as macrophages 
and DCs, are in nature especially sensitive to changes in 
their surroundings. In suboptimal culture conditions 
these cells may become stressed or damaged, or even react 
towards an unknown component in a culture medium, 
something that can activate DCs and consequently affect 
the results  [176] . Nonetheless, the most commonly used 
accompanying cell types in these co-culture models have 
been the DCs and macrophages, investigating how their 
responses towards particulate matter, pathogens and 
their subsequent effects on T-cell responses are influ-
enced by AECs  [67, 109, 110, 112, 113] . Both DCs and 
macrophages are very relevant cell types to investigate 
with AECs and both can be generated from monocytes, 
which are readily obtained in high quantities from buffy 
coats or full-blood samples  [177] .
 In the airways, AECs have been found to affect and in-
teract with cell types, such as mast cells, eosinophils, ILC2 
and basophils, and co-culture models with AECs could be-
come a powerful tool in further elucidating their roles in 
airway inflammation and homeostasis  [67] . Peripheral 
blood eosinophils have been used in some co-culture stud-
ies with primary nasal epithelial cells, mainly to evaluate the 
effect of AEC-soluble factors on eosinophil migration and 
activation, but also how eosinophil soluble factors affect 
nasal epithelium  [178–180] . Similar studies with AEC-con-
ditioned medium have also been used to investigate mast 
cell proliferation and one group has investigated mast cell 
adhesion to tracheal epithelial cells in a canine system  [181, 
182] . However, to the authors’ knowledge, ILC2s or baso-
phils have yet to be used in any AEC co-culture model.
 Airway co-culture models with one accompanying cell 
type have proven to be a great tool for investigating spe-
cific cell-cell interactions with AECs, and also to investi-
gate interactions between several cell types. Some groups 
have taken this even further, incorporating macrophages 
or fibroblasts in addition to DCs  [87, 90, 113, 159, 183] . 
This is a very interesting development for airway co-cul-
ture models, which in the future could potentially lead to 
complex multicell co-culture models, bringing us close to 
recreating airway tissues in vitro and becoming a rational 
supplement – or possible substitution – for in vivo  and ex 
vivo  studies.
 Culture Conditions 
 The culture conditions employed are critical for the 
characteristics of the resulting cell layer for both primary 
cells and cell lines  [184, 185] . As seen in  table 1 , different 
groups obtain different levels of polarization and TEER 
using the same cell lines. Besides inevitable variations in 
cell handling between laboratories and experimental set-
ups, other factors might also affect the properties of epi-
thelial cell layers. Early studies with intestinal epithelial 
cell culture models showed that differences in culture 
conditions, such as the coating of matrix proteins and cul-
ture medium, influenced the permeability and expression 
of transporter proteins  [186, 187] . Similar differences in 
culture conditions have also been reported to greatly af-
fect the growth and differentiation of primary airway ep-
ithelial cell cultures  [94, 188] . Growing a confluent polar-
ized epithelial layer also depends on the number of AECs 
seeded onto culture inserts. Most of the polarizing airway 
epithelial cell lines are most commonly used between day 
7 and 10  [72, 89, 98, 99, 107, 183] , similar to the use of 
primary bronchial and alveolar cells  [116, 127, 189] , al-
though some have reported using primary cells at later 
time points, such as on day 14  [90] . The seeding densities 
of AECs are generally between 10 5 and 10 6 cells per square 
centimetre. Although it has been reported to not directly 
affect their ability to form confluent and polarized mono-
layers, seeding densities appear to mostly influence how 
many days of culture are needed before confluence and 
polarization are reached  [98, 99, 190] .
 The inclusion of additional cell types in co-culture set-
ups can also influence culture conditions for the AECs in 
several ways. In a triple cell co-culture study by Lehmann 
et al.  [90] it was found that both the A549 and the 
16HBE14o– cell lines obtained significantly lower TEER 
values after the addition of macrophages and DCs. Fur-
thermore, the specific design and protocol for co-cultur-
ing also influences the ability of AECs to proliferate. A 
schematic representation of the most common co-culture 
models is provided in  figure 5 . Some co-culture protocols 
entail adding accompanying cells to the basal side of AECs 
by letting them attach to upended culture inserts ( fig. 5 ) 
 [72, 115, 167] . This step unfortunately leads to the full ex-
posure of the AECs to air (high humidity, 37  °  C, 5% CO 2 ) 
in the absence of culture medium, and we have found that 
such exposure severely damages epithelial polarization 
and decreases TEER by over 60% within 24 h  [72] .
 ALI or Liquid-Covered Conditions 
 One central decision when establishing an airway in 
vitro model is whether to culture the AECs at an ALI or 
under liquid-covered conditions. With AECs cultured on 
filter inserts it provides the opportunity to only supply 
medium to the basal side of the cells. This restriction in 
nutrients brings the AECs to an environment close to the 
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physiological situation. These ALI cultures can be used 
with both primary epithelial cells and certain epithelial 
cell lines. The precise culture techniques for ALI condi-
tions have been described for several airway epithelial cell 
lines  [92, 111, 191, 192] . 
 Primary cells obtained during bronchoscopy of nor-
mal human volunteers are normally cultured on tissue 
culture plates coated with human collagen and used in 
studies after at least one passage  [106] . These primary hu-
man bronchial epithelial cells can be cultured in ALI con-
ditions using a defined medium to drive a differentiation 
into ciliated and goblet cells with a high degree of polar-
ization  [185, 193] .  As most airway in vitro models build 
upon the work done with the intestinal epithelial cell line 
Caco-2  [95, 104] , which was cultured fully suspended in 
medium, initial work with airway epithelial cell lines were 
tested in similar conditions. Such liquid-covered condi-
tions also offer some advantages, as particle uptake and 
transfer studies are more straightforward with TEER be-
ing easily monitored. However, for models designed to 
represent the airways, liquid-covered conditions partly 
fail to reflect the physiological conditions under which 
the airway epithelium normally operates. In vivo , the api-
cal surface of AECs is exposed to air with only a thin lay-
er of liquid covered by a surfactant film  [22] . Several 
groups have suggested that culturing cells at an air-liquid 
interface plays an important role in the differentiation of 
respiratory epithelial cells and that AECs grown under 
ALI conditions undergo enhanced differentiation and at-
tain better bioelectrical properties due to the increased 
aerobic respiration compared with AECs immersed in 
medium  [89, 99, 131] . 
 Although the bronchial cell lines Calu-3 and 
16HBE14o– are generally considered to develop an ade-
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quate and favourable phenotype under liquid-covered 
conditions, a few studies have suggested that the ALI con-
dition may also be critical for the growth differentiation 
of these two cell lines  [100, 101] . A study by Grainger et 
al.  [89] showed that Calu-3 cells in ALI conditions pro-
duced a more columnar epithelium with a more rugged 
apical topography and greater glycoprotein secretion 
compared with cells cultured under liquid-covered con-
ditions. In their study, the authors observed secretory 
vesicles in cells grown under both conditions, but extra-
cellular glycoproteins were only detected at the cell sur-
face when ALI conditions were applied. However, they 
recognized that any secreted mucus consisting of glyco-
proteins would be dispersed and removed with the media 
at the apical membrane under liquid-covered conditions 
 [89] . Concurrent with other studies, the authors conclud-
ed that the Calu-3 cells at the ALI represent a more mor-
phologically correct model of the bronchial epithelium in 
comparison with Calu-3 cells cultured under liquid-cov-
ered conditions  [89, 151, 189] . However, Calu-3 cells ob-
tain substantially lower TEER values under ALI condi-
tions compared to culturing in liquid-covered condi-
tions. During liquid-covered conditions TEER values are 
often over 1000 Ω    ·    cm 2 but have been reported to reach 
as high as 2,500 Ω     ·     cm 2  [72, 106, 194] , whereas TEER 
 values when cultured under ALI are typically 300–
600 Ω    ·    cm 2  [89, 106] . Thus, it is possible that even with a 
better morphology Calu-3 TJ formation is not as com-
plete at the ALI and might not be optimal for all investi-
gations of the bronchial epithelium. 
 It remains unknown why the Calu-3 cell line obtains 
higher TEER values during liquid-covered conditions 
compared to ALI conditions. It could be a matter of culture 
conditions not yet being refined enough at ALI conditions 
and that future optimization of culture conditions in terms 
of the use of matrix proteins or RVWs (discussed below) 
could possibly enable the Calu-3 cell line to better polarize 
at an ALI, as described for the nasal RPMI 2650 cell line or 
A549 cells. In the same context, 16HBE14o– cells remain 
to be successfully cultured under ALI conditions, and fully 
submerged cultures are commonly favoured  [88] . There 
are a few examples of studies culturing 16HBE14o − in ALI 
conditions with positive staining for the TJ proteins ZO-1, 
occludin and the intercellular protein E-cadherin, but 
TEER values did not exceed 250 Ω    ·    cm 2  [93, 99] . 
 RWV 3D Culture 
 Over the last decade increasing effort has been made 
to utilize technology for creating 3D cell culture models 
to study cellular responses to external stimuli  [195–197] . 
Through a bioreactor technology known as rotating wall 
vessel, or RWV, a few studies have been published in 
which the A549 cell line was used to create a 3D model of 
the alveolar epithelium  [198, 199] . In brief, the RWV 
technology is an optimized suspension culture method 
in which cells are grown on coated microcarrier beads at 
low fluid-shear conditions inside cylindrical bioreactors, 
called slow-turning lateral vessels, STLV, or high aspect 
ratio vessels, HARV  [200] . Through improved 3D cell-
matrix and cell-cell interactions, the model showed sig-
nificant improvements on morphological and phenotyp-
ical characteristics compared with the traditional 2D 
models using the A549 cell line. These improvements in-
cluded the establishment of apical and basolateral polar-
ity, enhanced expression of TJs, extracellular matrix pro-
teins and extramembrane mucin localization  [198] . The 
RWV modelling of the epithelium does not allow for tra-
ditional TEER measurements, but the fact that the 3D 
model showed a clear increased expression of TJ proteins 
compared to traditional 2D models suggests an improved 
polarization and makes the A549 cell line suitable for fu-
ture co-culture studies using RWV technology.
 Optimization of Medium 
 As different media result in different cell phenotypes 
regardless of whether AECs are cultured at an ALI or in 
liquid-covered conditions, AEC culturing requires spe-
cialized medium in order to obtain morphologically rep-
resentative epithelial cells  [107, 184, 201] . Many of the 
airway epithelial cell lines, such as the RPMI 2650, Calu-3 
and 16HBE14o– cells, are cultured in MEM-based me-
dium  [72, 90, 98, 113, 167, 183] , whereas the A549 and 
H441 cell lines are cultured in RPMI-based medium  [72, 
90, 167] . The majority of co-culture models utilize AECs 
cultured on transwell inserts, where they are allowed to 
form monolayers and polarize for several days before use. 
As it is important to maintain the epithelial properties, 
the most common practice has been to simply add which-
ever additional cell type is to be tested to the transwell 
system using the specialized AEC culture medium. With 
good use of controls, these studies can still yield im-
portant results, but if the aim is to characterize and study 
in vivo interactions, such a change of recommended 
 medium for the accompanying cells without adaption 
and/or optimization could affect their responses and 
hence phenotypes. In our co-culture experiments with 
the 16HBE14o– bronchial cell line and monocyte-derived 
DCs, we investigated how the two cell types responded to 
each other’s medium. The 16HBE14o– cell line was found 
not to proliferate as readily in the culture medium recom-
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mended for culturing monocyte-derived DCs, whereas 
monocyte-derived DCs failed to preserve their immature 
phenotype in the AEC medium. The DCs upregulated co-
stimulatory receptors and produced pro-inflammatory 
cytokines, indicating a maturated profile when cultured 
in the recommended medium for the AECs  [72] . These 
results indicate that non-optimized culture medium for 
co-cultures affects results, making it incredibly important 
to determine the effect of a change in culture medium on 
each individual cell type. Optimizing culture mediums 
for more than one cell type can be done in several ways. 
By blending certain components of both recommended 
media it may be possible to find a medium which sup-
ports both or all cell types without affecting phenotypes 
 [72] . Another approach is to mix the different recom-
mended media at different ratios and find a composition 
suitable for both cell types. Although it might seem trivi-
al, this it is an important parameter to consider when de-
signing a co-culture model, especially in order to study 
the parameters of cells involved in activating or repress-
ing the immune response.
 Matrix Proteins 
 Primary cells from the airways are normally cultured 
on tissue culture plates coated with human collagen and 
fibronectin  [90, 106] . With the exception of a few alveolar 
cell lines, the AEC lines discussed in this review are also 
recommended to grow on surfaces coated with matrix 
proteins. Extracellular matrix proteins, including fibro-
nectin and collagen, enhance cell adherence. The base-
ment membrane in the airways is composed mainly of 
collagen fibers and, among the extracellular matrix pro-
teins, type 1 collagen results in the best differentiation of 
airway epithelium  [202, 203] . Coating of the culture sur-
face affects the polarization of primary cultured airway 
cells; however, both Calu-3 and 16HBE14o– cells have 
been reported to be able to form adequate barriers in the 
absence of any coating  [131, 185] . Probably in line with 
other findings but as yet unpublished, we found that coat-
ed inserts resulted in the most consistent TEER values 
when growing these two cell lines to confluency. For the 
nasal epithelial-derived cell line RPMI 2650, collagen 
coating is a prerequisite for monolayer formation and 
also leads to improved differentiation, functional polar-
ization and a significant TEER increase  [98] .
 Concluding Remarks 
 The mechanisms regulating airway responses to aller-
gens and other antigens are extremely complex and are 
influenced by the interaction of different cell types and 
cytokines in the airway microenvironment. Recreating 
such a complex environment in vitro using epithelial cell 
lines or primary cells as a field of research is still progress-
ing. Choosing how to design a co-culture model depends 
on various factors, including the experimental question 
being addressed together with the cost, training and ex-
pertise required to successfully establish, optimize and 
apply the model. Depending on which part of the airways 
one aims to investigate, there are multiple options on how 
to design a suitable model. This review has illustrated the 
diverse set of options available today in order to recreate 
certain aspects of the morphological, biochemical and 
immunological features of the airways. The most com-
monly used cell lines for different areas of the airways 
have been discussed together with important consider-
ations of the culture conditions. Recreating – or mimick-
ing – organs and tissues as complex as the airways stress-
es the importance of careful validation and a clear aim of 
the immunological mechanism of study before designing 
and utilizing any airway co-culture models.
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